Good morning :)
$
₹
Genmab AS

Genmab AS

GMAB

NASDAQ
$55.100.74% (-0.41)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Biotechnology

Large Cap

With a market cap of $33.8B the stock is ranked 432

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

43.24
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

5.88
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.27
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

8.56
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

19.08%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 12 analysts reports

Buy
11 analysts
Hold
1 analyst
Sell
0 analyst

Price Upside

+17%

Earnings Growth

-31.58%

Rev. Growth

+709.65%

See Detailed Forecast

Company Profile

Company Profile

P/E Ratio
50.67
50.67
1Y Return
36.27%
36.27%
Buy Reco %
79.31
79.31
P/E Ratio
28.90
28.90
1Y Return
58.2%
58.2%
Buy Reco %
35.29
35.29
P/E Ratio
—
—
1Y Return
37.21%
37.21%
Buy Reco %
78.57
78.57
P/E Ratio
32.21
32.21
1Y Return
24.59%
24.59%
Buy Reco %
81.25
81.25
P/E Ratio
21.24
21.24
1Y Return
51.74%
51.74%
Buy Reco %
67.85
67.85
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Financials

Financials

Income

Balance Sheet

Cash Flow

1
0.4
1
0
0.8
0
1.1
0.3
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue0.600.775.546.440.100.921.021.050.891.15
Net Income0.190.201.263.840.020.330.400.030.050.30
Net Profit Margin31.84%26.05%22.85%59.69%27.27%36.32%39.23%2.93%5.91%26.23%

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Genmab AS 43.245.888.56
AbbVie Inc50.6750.450.60
Amgen Inc28.9021.552.77

Price Comparison

Price Comparison

Compare GMAB with any stock or ETF
Compare GMAB with any stock or ETF
Comparing from
GMAB
ABBV
AMGN
Loading...

Frequently asked questions

  1. Genmab AS (GMAB) share price today is $55.10 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $55.98 and a day low of $53.76.

  2. Genmab AS stock trades on NASDAQ under the ticker symbol GMAB.

  3. Genmab AS's market capitalization is $33.77B as of November 5, 2026 at 2:29 AM IST.

  4. Genmab AS's price-to-earnings (P/E) ratio is 43.24 as of November 4, 2026.

  5. Genmab AS's price-to-book (P/B) ratio is 5.88 as of November 4, 2026.

  6. Yes, You can buy Genmab AS shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Genmab AS shares in three steps: 1. Search Genmab AS on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Genmab AS trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Genmab AS (GMAB) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1814 shares at the current price of $55.10.

Loading...